StonvexLoading…
StonvexStonvexStonvexCore line items from MTN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-07-31 | Annual 2024 2024-07-31 | Annual 2023 2023-07-31 | Annual 2022 2022-07-31 |
|---|---|---|---|---|
Revenue | $2.96B | $2.89B | $2.89B | $2.53B |
Operating Income | $559.96M | $488.85M | $504.42M | $601.73M |
Net Income | $280.00M | $231.10M | $265.82M | $347.92M |
EPS (Diluted) | $7.53 | $6.09 | $6.69 | $8.55 |
Total Assets | $5.78B | $5.69B | $5.95B | $6.32B |
Total Liabilities | $5.02B | $4.66B | $4.61B | $4.47B |
Cash & Equivalents | $440.29M | $322.83M | $562.98M | $1.11B |
Free Cash Flow OCF − CapEx | $319.68M | $377.82M | $322.94M | $517.68M |
Shares Outstanding | 37.20M | 37.96M | 39.76M | 40.69M |